Cargando…
Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities
Cas12a enzymes are quickly being adopted for use in a variety of genome-editing applications. These programmable nucleases are part of adaptive microbial immune systems, the natural diversity of which has been largely unexplored. Here, we identified novel families of Type V-A CRISPR nucleases throug...
Autores principales: | Aliaga Goltsman, Daniela S., Alexander, Lisa M., Devoto, Audra E., Albers, Justine B., Liu, Jason, Butterfield, Cristina N., Brown, Christopher T., Thomas, Brian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757703/ https://www.ncbi.nlm.nih.gov/pubmed/33146573 http://dx.doi.org/10.1089/crispr.2020.0043 |
Ejemplares similares
-
Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
por: Chaudhari, Hemangi G., et al.
Publicado: (2020) -
One-Step Homology Mediated CRISPR-Cas Editing in Zygotes for Generating Genome Edited Cattle
por: Park, Ki-Eun, et al.
Publicado: (2020) -
Fast and cloning‐free CRISPR/Cas9‐mediated genomic editing in mammalian cells
por: Manna, Paul T., et al.
Publicado: (2019) -
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability
por: Alexander, Lisa M., et al.
Publicado: (2023) -
Simultaneous determination of steroid hormones and pharmaceuticals in killer whale (Orcinus orca) faecal samples by liquid chromatography tandem mass spectrometry
por: Ross, Andrew R S, et al.
Publicado: (2023)